Andrew J Cowan

12PUBLICATIONS
79CO-AUTHORS
Medical infection agents (incl. prions)Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Fuzzy computationGene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|May 02, 2026
Leveraging AI to Evaluate Minimal Residual Disease Endpoint Surrogacy in Multiple Myeloma.

|Apr 23, 2026
Functional high-risk phenotype predicts poor survival in multiple myeloma independent of front-line treatment: A secondary analysis of CIBMTR data.

|Jan 27, 2026
Past, Present, and Future of Dexamethasone in Multiple Myeloma and AL Amyloidosis.

Rahul Banerjee, Tracy King, Beth Faiman

|Jan 14, 2026
Time-Series Clustering Captures Patterns of Early Immune Effector Cell-Associated Hematotoxicity That Are Predictable Using Tree-Based Models.

Emily C Liang, Yein Jeon, Yang Qiao

|Oct 10, 2025
Long-term follow-up of dose-dense brentuximab vedotin, ifosfamide, carboplatin and etoposide in second-line treatment of relapsed/refractory classical Hodgkin lymphoma.

Ryan C Lynch, Ryan D Cassaday, Stephen D Smith

|Aug 08, 2025
Real-World Experience with Teclistamab for Relapsed/Refractory Multiple Myeloma from the US Myeloma Immunotherapy Consortium.

Beatrice M Razzo, Shonali Midha, Andrew J Portuguese

Pageof 2

Frequent Collaborators

7 joint publications

Rahul Banerjee

6 joint publications

Andrew J Portuguese

3 joint publications

Larry D Anderson

3 joint publications

Jack Khouri